Exelon Corporation reported its fourth-quarter 2024 results, posting an adjusted earnings per share (EPS) of $0.64, surpassing the $0.59 estimate. The company generated sales of $5.471 billion, exceeding the anticipated $4.742 billion. Exelon also announced a capital expenditure plan of $38 billion over the next four years, targeting a 7.4% growth in its rate base and a compound annual growth rate (CAGR) of 5-7% for EPS. Other companies reporting their fourth-quarter results include CME Group, which achieved an adjusted EPS of $2.52 against an estimate of $2.44, and sales of $1.525 billion, slightly above the $1.519 billion estimate. QuidelOrtho also reported an adjusted EPS of $0.63, beating expectations of $0.59, with sales of $707.80 million surpassing the $699.16 million estimate. GXO Logistics reported an adjusted EPS of $1.00, exceeding the $0.94 estimate, with sales of $3.30 billion, above the $3.22 billion estimate. In addition, Cognex reported an adjusted EPS of $0.20, beating the $0.16 estimate, and sales of $229.684 million, exceeding the $220.664 million estimate. GE HealthCare reported adjusted EPS of $1.45, up from $1.18 the previous year, with revenues increasing by 2% to $5.3 billion. Zoetis reported an adjusted EPS of $1.40 and revenues of $2.32 billion, reflecting a 5% growth year-over-year. Dexcom's fourth-quarter revenue rose 8% to $1.11 billion, though its adjusted EPS of $0.45 fell short of the $0.50 estimate.